Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Advanced Technology Laboratorie's (ATL) breast mass Doppler gets unanimous panel approval

This article was originally published in Clinica

Executive Summary

Advanced Technology Laboratories' (ATL, US) Ultramark high definition imaging (HDI) ultrasound with 2D Doppler received a unanimous approval recommendation for use in evaluating breast masses from the FDA's Radiological Devices Advisory Panel at its December 11th meeting. The device was being considered for evaluating solid breast lesions greater than one centimetre to reduce the number of breast biopsies.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts